| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2021 | RISERX LLC | 11881 E PONCE DE LEON | TUCSON | AZ | 85749-8672 | PIMA | USA | R43HL160334 | Optimizing Small Molecule Lipoxin-Mimicking FPR2 Agonists for the Treatment of Acute Respiratory Distress Syndrome | 000 | 1 | NIH | 3/8/2024 | $0 |
| 2024 | 2021 | RISERX LLC | 11881 E PONCE DE LEON | TUCSON | AZ | 85749-8672 | PIMA | USA | R43AG072963 | Optimizing Small Molecule Lipoxin-Mimicking FPR2 Agonists for the Treatment of Alzheimers Disease | 000 | 1 | NIH | 2/22/2024 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $747,946 ) |
| 2021 | 2021 | RISERX, LLC | 11881 E PONCE DE LEON | TUCSON | AZ | 85749-8672 | PIMA | USA | R43AG072963 | Optimizing Small Molecule Lipoxin-Mimicking FPR2 Agonists for the Treatment of Alzheimers Disease | 000 | 1 | NIH | 8/31/2021 | $449,931 |
| 2021 | 2021 | RISERX, LLC | 11881 E PONCE DE LEON | TUCSON | AZ | 85749-8672 | PIMA | USA | R43HL160334 | Optimizing Small Molecule Lipoxin-Mimicking FPR2 Agonists for the Treatment of Acute Respiratory Distress Syndrome | 000 | 1 | NIH | 9/20/2021 | $298,015 |
|
|